Form 8-K Verrica Pharmaceuticals For: May 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Verrica Pharmaceuticals (VRCA) PT Raised to $12 at Jefferies
May 14, 2024 9:35 AM EDTJefferies analyst Glen Santangelo raised the price target on Verrica Pharmaceuticals (NASDAQ: VRCA) to $12.00 (from $10.00) while maintaining a Buy rating.
The analyst comments "Updating model to reflect 1Q results. Overall, we remain encouraged with the launch and continue to see opportunity for... More
